Effects of pallidotomy and levodopa on walking and reaching movements in Parkinson's disease

Movement Disorders

Volumn 18, Issue 9, 2003, Pages 1008-1017

  Bastian, Amy J ^a,b,c   Kelly, Valerie E ^c   Perlmutter, Joel S ^d   Mink, Jonathan W ^e  

^a KENNEDY KRIEGER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Gait; Lebodopa; Pallidotomy; Parkinson's disease; UPDRS

Indexed keywords

ANTIPARKINSON AGENT; LEVODOPA;

ADULT; AGED; ARTICLE; BASAL GANGLION; BODY MOVEMENT; BODY POSTURE; BRADYKINESIA; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GAIT; HUMAN; KINEMATICS; MALE; MEDICAL ASSESSMENT; MOTOR PERFORMANCE; PALLIDOTOMY; PARKINSON DISEASE; PONS ANGLE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RIGIDITY; SCORING SYSTEM; STANDARD; THALAMOCORTICAL TRACT; WALKING SPEED;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; BIOMECHANICS; COMBINED MODALITY THERAPY; FEMALE; GAIT; GLOBUS PALLIDUS; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOVEMENT; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; STEREOTAXIC TECHNIQUES; TREATMENT OUTCOME;

EID: 0141836915     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10494     Document Type: Article

References (40)

1. Guridi J, Lozano AM. A brief history of pallidotomy. Neurosurgery 1997:41:1169-1180.
2. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992;76:53-61.
3. Kishore A, Turnbull IM, Snow BJ, et al. Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease. Six-month follow-up with additional 1-year observations. Brain 1997:120:729-737.
4. Lang AE, Lozano AM, Montgomery E, Duff J, Tasker R, Hutchinson W. Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med 1997;337:1036-1042.
5. Samuel M, Caputo E, Brooks DJ, et al. A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications. Brain 1998;121:59-75.
6. Shannon KM, Penn RD, Kroin JS, et al. Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy and adverse effects at 6 months in 26 patients. Neurology 1998;50:434-438.
7. Eskandar E, Shinobu LA, Penney JB Jr, Cosgrove GR. Non-microelectrode guided stereotactic pallidotomy for Parkinson's disease: surgical technique and results. Stereotact Funct Neurosurg 1999;72:245.
8. de Bie RM, Schuurman PR. de Haan PS, Bosch DA, Speelman JD. Unilateral pallidotomy in advanced Parkinson's disease: a retrospective study of 26 patients. Mov Disord 1999;14:951-957.
9. Samii A, Turnbull IM, Kishore A, et al. Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study. Brain 1999;122:417-425.
10. Schrag A, Samuel M, Caputo E, et al. Unilateral pallidotomy for Parkinson's disease: results after more than 1 year. J Neurol Neurosurg Psychiatry 1999;67:511-517.
11. Lang AE, Duff J, Saint-Cyr JA, et al. Posteroventral medial pallidotomy in Parkinson's disease. J Neurol 1999;246(Suppl. 2): II28-II41.
12. Eskandar EN, Shinobu LA, Penney JB Jr, Cosgrove GR, Counihan TJ. Stereotactic pallidotomy performed without using microelectrode guidance in patients with Parkinson's disease: surgical technique and 2-year results. J Neurosurg 2000;92:375-383.
13. Pal PK, Samii A, Kishore A, et al. Long term outcome of unilateral pallidotomy: follow up of 15 patients for 3 years. J Neurol Neurosurg Psychiatry 2000;69:337-344.
14. Dogali M, Fazzini E, Kolodny E, et al. Stereotactic ventral Pallidotomy for Parkinson's disease. Neurology 1995;45:753-761.
15. Baron MS, Vitek JL, Bakay RA, et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 1996;40:355-366.
16. Lozano AM, Lang AE, Galvez-Jimenez N, et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 1995;346:1383-1387.
17. Lang AE, Fahn S. Assessment of Parkinson's disease. In: Munsat T, editor. Quantification of neurological deficit. Boston: Butterworth; 1989. p 285-309.
18. Bastian AJ, Mink JW, Kelly VE, Flekal JA. Additive effects of L-dopa and pallidotomy on the kinematics of walking but not reaching. Soc Neurosci Abstr 1998;24:409.
19. Mink JW, Kelly VE, Bastian AJ. Effect of pallidotomy on walking and reaching in Parkinson's Disease. International Basal Ganglia Society, Bay of Islands, New Zealand, February, 2001.
20. Peterson CR, Calvert JC, Canzoneri J, Leavitt LA, McCutchen JJ, Schwartz L. Quantitative analysis of the effects of L-dopa on gait in 26 patients with Parkinsonism. Am J Phys Med 1972;51:171-181.
21. Blin O, Ferrandez AM, Pailhous J, Serratrice G. Dopa-sensitive and dopa-resistant gait parameters in Parkinson's disease. J Neurol Sci 1991;103:51-54.
22. Weller C, O'Neill CJ, Charlett A, et al. Defining small differences in efficacy between anti-parkinsonian agents using gait analysis: a comparison of two controlled release formulations of levodopa/decarboxylase inhibitor. Br J Clin Pharmacol 1993;35:379-385.
23. Gaspar P, Stepniewska I, Kaas JH. Topography and collateralization of the dopaminergic projections to motor and lateral prefrontal cortex in owl monkeys. J Comp Neurol 1992;325:1-21.
24. Jackson A, Crossman AR. Nucleus tegmenti pedunculopontinus: efferent connections with special reference to the basal ganglia, studied in the rat by anterograde and retrograde transport of horse-radish peroxidase. Neuroscience 1983;10:725-765.
25. Milner KL, Mogenson GJ. Electrical and chemical activation of the mesencephalic and subthalamic locomotor regions in freely moving rats. Brain Res 1988;452:273-285.
26. Seigel KL, Metman LV. Effects of bilateral posteroventral pallidotomy on gait of subjects with Parkinson disease. Arch Neurol 2000;57:198-204.
27. Defebvre LJ, Krystkowiak P, Blatt JL, et al. Influence of pallidal stimulation and levodopa on gait and preparatory postural adjustments in Parkinson's disease. Mov Disord 2002;17:76-83.
28. Castiello U, Bennett KM, Bonfiglioli C, Peppard RF. The reach-to-grasp movement in Parkinson's disease before and after dopaminergic medication. Neuropsychologia 2000;38:46-59.
29. Kelly VE, Hyngstrom AS, Rundle MM, Bastian AJ. Interaction of levodopa and cues on voluntary reaching in Parkinson's disease. Mov Disord 2002;17:38-44.
30. Pfann KD, Penn RD, Shannon KM, Corcos DM. Pallidotomy and bradykinesia: implications for basal ganglia function. Neurology 1998;51:796-803.
31. Bennett KM, O'Sullivan JD, Peppard RF, McNeill PM, Castiello U. The effect of unilateral posteroventral pallidotomy on the kinematics of the reach to grasp movement. J Neurol Neurosurg Psychiatry 1998;65:479-487.
32. Limousin P, Brown RG, Jahanshahi M, et al. The effects of posteroventral pallidotomy on the preparation and execution of voluntary hand and arm movements in Parkinson's disease. Brain 1999;122:315-327.
33. Jankovic J, Ben-Arie L, Schwartz K, et al. Movement and reaction times and fine coordination tasks following pallidotomy. Mov Disord 1999;14:57-62.
34. Kimber TE, Tsai CS, Semmler J, Brophy BP, Thompson PD. Voluntary movement after pallidotomy in severe Parkinson's disease. Brain 1999;122:895-906.
35. Krack P, Pollak P, Limousin P, Benabid AL. Levodopa-inhibiting effect of pallidal surgery. Ann Neurol 1997;42:129-130.
36. Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 1994;117:859-876.
37. Mink JW, Thach WT. Basal ganglia motor control. III. Pallidal ablation: normal reaction time, muscle cocontraction, and slow movement. J Neurophysiol 1991;65:330-351.
38. Wenger KK, Musch KL, Mink JW. Impaired reaching and grasping after focal inactivation of globus pallidus pars interna in the monkey. J Neurophysiol 1999;82:2049-2060.
39. Marsden CD, Obeso JA. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain 1994; 117:877-897.
40. Berardelli A, Rothwell JC, Thompson PD, Hallett M. Pathophysiology of bradykinesia in Parkinson's disease. Brain 2001;124: 2131-2146.